<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34687421</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1865-3774</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>115</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of hematology</Title>
          <ISOAbbreviation>Int J Hematol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.</ArticleTitle>
        <Pagination>
          <StartPage>424</StartPage>
          <EndPage>427</EndPage>
          <MedlinePgn>424-427</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12185-021-03243-2</ELocationID>
        <Abstract>
          <AbstractText>Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccination in a 53-year-old woman. Blood examination at diagnosis showed hemolytic anemia with a positive Coombs test and thrombocytopenia. Hypocomplementemia and the presence of lupus anticoagulant indicated a strong association with SLE. Prednisolone administration rapidly restored hemoglobin level and platelet count. This case suggests that mRNA COVID-19 vaccination may cause an autoimmune disorder. Physicians should be aware of this adverse reaction by mRNA COVID-19 vaccination and should consider the benefits and risks of vaccination for each recipient.</AbstractText>
          <CopyrightInformation>© 2021. Japanese Society of Hematology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hidaka</LastName>
            <ForeName>Daisuke</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan. daisuperstition19@yahoo.co.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogasawara</LastName>
            <ForeName>Reiki</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sugimura</LastName>
            <ForeName>Shunsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujii</LastName>
            <ForeName>Fumiaki</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kojima</LastName>
            <ForeName>Keisuke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagai</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ebata</LastName>
            <ForeName>Ko</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okada</LastName>
            <ForeName>Kohei</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kobayashi</LastName>
            <ForeName>Naoki</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogasawara</LastName>
            <ForeName>Masahiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imamura</LastName>
            <ForeName>Masahiro</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ota</LastName>
            <ForeName>Shuichi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology, Sapporo Hokuyu Hospital, Higashi Sapporo 6-6, Shiroishi-ku, Sapporo, 0030006, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Hematol</MedlineTA>
        <NlmUniqueID>9111627</NlmUniqueID>
        <ISSNLinking>0925-5710</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9PHQ9Y1OLM</RegistryNumber>
          <NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N38TVC63NU</RegistryNumber>
          <NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C536380">Evans Syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000744" MajorTopicYN="N">Anemia, Hemolytic, Autoimmune</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006403" MajorTopicYN="N">Hematologic Tests</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016553" MajorTopicYN="N">Purpura, Thrombocytopenic, Idiopathic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AIHA</Keyword>
        <Keyword MajorTopicYN="N">COVID-19 mRNA vaccine</Keyword>
        <Keyword MajorTopicYN="N">Evans syndrome</Keyword>
        <Keyword MajorTopicYN="N">ITP</Keyword>
        <Keyword MajorTopicYN="N">SLE</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>12</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34687421</ArticleId>
        <ArticleId IdType="pmc">PMC8536917</ArticleId>
        <ArticleId IdType="doi">10.1007/s12185-021-03243-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s12185-021-03243-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al.  Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId>
            <ArticleId IdType="pmc">PMC7745181</ArticleId>
            <ArticleId IdType="pubmed">33301246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roest S, Hoek RAS, Manintveld OC. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1968–1970. doi: 10.1056/NEJMc2104281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2104281</ArticleId>
            <ArticleId IdType="pubmed">33882226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ganzel C, Ben-Chetrit E. Immune thrombocytopenia following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. Isr Med Assoc J. 2021;23:341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34155844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al.  Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96:534–537. doi: 10.1002/ajh.26132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.26132</ArticleId>
            <ArticleId IdType="pmc">PMC8014568</ArticleId>
            <ArticleId IdType="pubmed">33606296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wise J. Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show. BMJ. 2021;373:n1489. doi: 10.1136/bmj.n1489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.n1489</ArticleId>
            <ArticleId IdType="pubmed">34112639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen DL, Moller S, Andersen K, Gaist D, Frederiksen H. Evans syndrome in adults: incidence, prevalence, and survival in a nationwide cohort. Am J Hematol. 2019;94:1081–1090. doi: 10.1002/ajh.25574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.25574</ArticleId>
            <ArticleId IdType="pubmed">31292991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, et al.  Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014;124:2930–2936. doi: 10.1182/blood-2014-06-583021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2014-06-583021</ArticleId>
            <ArticleId IdType="pubmed">25232059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, et al.  The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114:3167–3172. doi: 10.1182/blood-2009-04-215368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-04-215368</ArticleId>
            <ArticleId IdType="pubmed">19638626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al.  2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151–1159. doi: 10.1136/annrheumdis-2018-214819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2018-214819</ArticleId>
            <ArticleId IdType="pubmed">31383717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al.  Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–2686. doi: 10.1002/art.34473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.34473</ArticleId>
            <ArticleId IdType="pmc">PMC3409311</ArticleId>
            <ArticleId IdType="pubmed">22553077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al.  Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId>
            <ArticleId IdType="pmc">PMC7787219</ArticleId>
            <ArticleId IdType="pubmed">33378609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brito S, Ferreira N, Mateus S, Bernardo M, Pinto B, Lourenco A, et al.  A case of autoimmune hemolytic anemia following COVID-19 messenger ribonucleic acid vaccination. Cureus. 2021;13:e15035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8200779</ArticleId>
            <ArticleId IdType="pubmed">34150386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murdych TM. A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine. Int J Lab Hematol. 2021 doi: 10.1111/ijlh.13653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijlh.13653</ArticleId>
            <ArticleId IdType="pmc">PMC8444646</ArticleId>
            <ArticleId IdType="pubmed">34258873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerber GF, Yuan X, Yu J, Cher BAY, Braunstein EM, Chaturvedi S, et al.  COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood. 2021;137:3670–3673. doi: 10.1182/blood.2021011548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.2021011548</ArticleId>
            <ArticleId IdType="pmc">PMC8099541</ArticleId>
            <ArticleId IdType="pubmed">33945618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med. 1951;87:48–65. doi: 10.1001/archinte.1951.03810010058005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.1951.03810010058005</ArticleId>
            <ArticleId IdType="pubmed">14782741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norton A, Roberts I. Management of Evans syndrome. Br J Haematol. 2006;132:125–137. doi: 10.1111/j.1365-2141.2005.05809.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2141.2005.05809.x</ArticleId>
            <ArticleId IdType="pubmed">16398647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR. Emergence of new onset SLE following SARS-CoV-2 vaccination. QJM. 2021 doi: 10.1093/qjmed/hcab229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcab229</ArticleId>
            <ArticleId IdType="pubmed">34450645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaur P, Agrawat H, Shukla A. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey. Rheumatol Int. 2021;41:1601–1605. doi: 10.1007/s00296-021-04938-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-021-04938-9</ArticleId>
            <ArticleId IdType="pmc">PMC8249840</ArticleId>
            <ArticleId IdType="pubmed">34213580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shlamovitz GZ, Johar S. A case of Evans’ syndrome following influenza vaccine. J Emerg Med. 2013;44:e149–e151. doi: 10.1016/j.jemermed.2012.01.060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jemermed.2012.01.060</ArticleId>
            <ArticleId IdType="pubmed">22796025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vadlamudi G, Hong L, Keerthy M. Evans syndrome associated with pregnancy and COVID-19 infection. Case Rep Obstet Gynecol. 2020;2020:8862545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7441452</ArticleId>
            <ArticleId IdType="pubmed">32850163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarza J, Von Horoch J, Aguayo N, Baez E. Evans syndrome associated with antiphospholipid antibodies in a patient with SARS-COV-2 infection. Hematol Transfus Cell Ther. 2020;42:309–312. doi: 10.1016/j.htct.2020.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.htct.2020.08.003</ArticleId>
            <ArticleId IdType="pmc">PMC7441956</ArticleId>
            <ArticleId IdType="pubmed">32864578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demir NA, Basturk A, Ural O, Sumer S, Erdogdu B, Kiratli HE, et al.  A case of Evans syndrome secondary to COVID-19. Blood Transfus. 2021;19:85–88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7850926</ArticleId>
            <ArticleId IdType="pubmed">33263526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Georgy JT, Jayakaran JAJ, Jacob AS, Gunasekaran K, Korula PJ, Devasia AJ, et al.  Evans syndrome and immune thrombocytopenia in two patients with COVID-19. J Med Virol. 2021;93:2642–2644. doi: 10.1002/jmv.26906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.26906</ArticleId>
            <ArticleId IdType="pmc">PMC8013600</ArticleId>
            <ArticleId IdType="pubmed">33634495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv. 2021;5:2794–2798. doi: 10.1182/bloodadvances.2021004957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/bloodadvances.2021004957</ArticleId>
            <ArticleId IdType="pmc">PMC8276576</ArticleId>
            <ArticleId IdType="pubmed">34255033</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
